Identification of mutations in seven Chinese patients with X-linked chronic granulomatous disease

Blood

Volumn 88, Issue 10, 1996, Pages 4021-4028

  Hui, Y F ^a   Chan, S Y ^a   Lau, Y L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; DNA FRAGMENT; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GRANULOMATOSIS; HUMAN; MALE; NITROBLUE TETRAZOLIUM TEST; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; X CHROMOSOME LINKED DISORDER;

EID: 0029803959     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.4021.bloodjournal88104021     Document Type: Article

References (55)

1. 558. Immunodeficiency 4:289, 1993
2. Åhlin A, de Boer M, Roos D, Leusen J, Smith CIE, Sundin U, Rabbani H, Palmbald J, Elinder G: Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 84:1386, 1995
3. Smith RM, Curnutte JT: Molecular basis of chronic granulomatous disease. Blood 77:673, 1991
4. Klebanoff SJ: Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol 12:117, 1975
5. Francke U, Ochs HD, de Martinville B, Giacalone J, Lindgren V, Distèche C, Pagon RA, Hofker MH, van Ommen GJB, Pearson PL, Wedgewood RJ: Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 37:250, 1985
6. Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, Cole FS, Curnutte JT, Orkin SH: Cloning the gene for an inherited human disorder - Chronic granulomatous disease - on the basis of its chromosomal location. Nature 322:32, 1986
7. Curnutte JT: Molecular basis of the autosomal recessive forms of chronic granulomatous disease. Immunodef Rev 3:149, 1992
8. Dinauer MC, Pierce EA, Bruns GAP Curnutte JT, Orkin SH: Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86:1729, 1990
9. Volpp BD, Nauseef WM, Donelson JE Moser DR, Clark RA: Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci USA 86:7195, 1986
10. c-src. Science 248:727, 1990
11. phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem J 296:557, 1993
12. phox. Biochim Biophys Res Commun 199:1378, 1994
13. Zhen S, Vazquez N, Zhan S Green E, Chancock SJ: Gene structure and expression of the newly defined component of the NADPH-oxidase, p40-phox. Blood 86:261a, 1995 (abstr, suppl 1)
14. Thrasher AJ, Keep NH, Wientjes F, Segal AW: Chronic granulomatous disease. Biochim Biophys Acta 1227:1, 1994
15. de Boer M, Bolscher BGJM, Dinauer MC, Orkin SH, Smith CIE, Åhlin A, Weening RS, Roos D:. Splice site mutations are a common cause of X-linked chronic granulomatous disease. Blood 80:1553, 1992
16. Bolscher BGJM, de Boer M, de Klein A, Weening RS, Roos D: Point mutations in the β-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood 77:2482, 1991
17. Rabbani H, de Boer M, Åhlin A, Sundin U, Elinder G, Hammarström L, Palmblad J, Smith CIE, Roos D: A 40-base-pair duplication in the gp91-phox gene leading to X-linked chronic granulomatous disease. Eur J Haematol 51:218, 1993
18. 558. J Clin Invest 94:1205, 1994
19. Ariga T, Sakiyama Y, Matsumoto S: Two novel point mutations in the cytochrome b 558 heavy chain gene, detected in two Japanese patients with X-linked chronic granulomatous disease. Hum Genet 94:441, 1994
20. Ariga T, Sakiyama Y, Matsumoto S: A 15-base pair (bp) palindromic insertion associated with a 3-bp deletion in exon 10 of the gp91-phox gene, detected in two patients with X-linked chronic granulomatous disease. Hum Genet 96:6, 1995
21. Azuma H, Oomi H, Sasaki, Kawabata I, Sakaino T, Koyano S, Suzutani T, Nunoi H, Okuno A: A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. Blood 85:3274, 1995
22. Dinauer MC, Curnutte JT, Rosen H, Rosen H, Orkin SH: A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. J Clin Invest 84:2012, 1989
23. Lau YL, Wong SN, Lawton JWM, Chow CB: Chronic granulomatous disease: A different pattern in Hong Kong? J Paediatr Child Health 27:235, 1991
24. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
26. Casanova JL, Pannetier C, Jaulin C, Kourilsky P: Optimal conditions for directly sequencing double-stranded PCR products with sequences. Nucleic Acids Res 18:4028, 1990
27. Parkos CA, Quinn MT, Sheets S, Jesaitis AJ: The structure of the human neutrophil plasma membrane b-type cytochrome involved in superoxide production, in Jesaitis AJ, Dratz EA (eds): The Molecular Basis of Oxidative Damage by Leukocytes. Boca Raton, FL, CRC, 1992, p 45
28. DeLeo FR, Yu L, Burritt JB, Loetterle LR, Bond CW, Jesaitis AJ, Quinn MT: Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc Natl Acad Sci USA 92:7110, 1995
29. 558. J Clin Invest 87:352, 1991
30. de Mendez I, Garrett MC, Adams AG, Leto TL: Role of p67-phox SH3 domains in assembly of the NADPH oxidase system. J Biol Chem 269:16326, 1994
31. Rotrosen D, Leto TL: Phosphorylation of neutrophil 47kDa cytosolic oxidase factor. Translocation to membrane is associated with distinct phosphorylation events. J Biol Chem 265:19910, 1990
32. Kleinberg ME, Mital DA, Rotrosen D, Malech HL: Characterization of a phagocytic cytochrome b558 91-kilodalton subunit functional domain: Identification of peptide sequence and amino acids essential for activity. Biochemistry 31:2686, 1992
33. 558 that leads to phagocyte NADPH oxidase activation in vitro. Biochemistry 33:2490, 1994
34. -245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. Biochem J 284:781, 1992
35. 558: The flavin-binding component of the phagocyte NADPH oxidase. Science 256:1459, 1992
36. 558, a component of the phagocyte NADPH oxidase, is a flavoprotein. Biochem Biophys Res Commun 186:1368, 1992
37. Segal AW: Structure of the NADPH-oxidase: Membrane components. Immunodeficiency 4:167, 1993
38. Creighton TE: Proteins: Structures and Molecular Properties (ed 2). New York, NY, W.H. Freeman, 1993, p 249
39. Quinn MT, Mullen ML, Jesaitis AJ: Human neutrophil cytochrome b contains multiple hemes. Evidence for heme associated with both subunits. J Biol Chem 267:7303, 1992
40. Wierenga RK, Terpstra P, Hol WGJ: Prediction of the occurrence of the ADP-binding βαβ-fold in proteins, using an amino acid sequence fingerprint. J Mol Biol 187:101, 1986
41. Krawczak M, Cooper DN: Gene deletions causing human genetic disease: Mechanism of mutagenesis and the role of the local DNA sequence environment. Hum Genet 86:425, 1991
42. Haltia T, Freire E: Forces and factors that contribute to the structural stability of membrane proteins. Biochim Biophys Acta 1241:295, 1995
43. Curnutte JT: Chronic granulomatous disease: The solving of a clinical riddle at the molecular level. Clin Immunol Immunopathol 67:S2, 1993
44. Cooper DN, Krawczak M: Mechanisms of insertional mutagenesis in human genes causing genetic disease. Hum Genet 87:409, 1991
45. Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, Åhlin A, Nemet K, Hossle JP, Bernatowska-Matuszkiewicz E, Middleton-Price H: Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87:1663, 1996
46. Curnutte JT: Disorders of phagocyte function, in Huffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology: Basic Principles and Practice. New York, NY, Churchill Livingston, 1995, p 792
47. Akli S, Chelly J, Mezard C, Gardy S, Kahn A, Poenaru L: A "G" to "A" mutation at position -1 of a 5′ splice site in a late infantile form of Tay-Sachs disease. J Biol Chem 265:7324, 1990
48. Weil D, D'Alessio M, Ramirez F, de Wet W, Cole WG, Chan D, Bateman JF: A base substitution in the exon of a collagen gene causes alternative splicing and creates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome type VII. EMBO J 8:1705, 1989
49. Andrews LG, Markert ML: Exon skipping in purine nucleo-side phosphorylase mRNA processing leading to severe immunodeficiency. J Biol Chem 267:7834, 1992
50. +-thalassemia. Proc Natl Acad Sci USA 86:1041, 1989
51. -1 to T) in a 5′ splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. Am J Hum Genet 54:54, 1994
52. Berg LP, Grundy TB, Thomas F, Millar DS, Green PJ, Slomski R, Reiss J, Kakkar VV, Cooper DN: De novo splice site mutation in the antithrombin HI (AT3) gene causing venous thrombosis: Demonstration of exon skipping by ectopic transcript analysis. Genomics 14:1359, 1992
53. Grandchamp B, Picat C, de Rooij F, Beaumont C. Wilson P, Deybach JC, Nordmann Y: A point mutation G → A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyria. Nucleic Acids Res 17:6637, 1989
54. Robberson BL, Cote GJ, Berget SM: Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 10:84, 1990
55. Lewin B: Alternatives for splicing: Recognizing the ends of introns. Cell 22:324, 1980